AI-assisted, human-published
08/13/2026 /Funding Events
Remepy Raises $36 Million in Series A Funding for Hybrid Drug Development
Remepy secures $36 million to advance co-development partnerships and support the global Phase III clinical development of Hybridopa for Parkinson's disease.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com